<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药物简讯 | wechat-feeds</title><link>http://MzI4OTIzMzcwMw.favicon.privacyhide.com/favicon.ico</link><description>【国内外药讯，医药市场，医药数据分享】</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 17 Jun 2021 10:03:10 +0800</pubDate><image><url>http://MzI4OTIzMzcwMw.favicon.privacyhide.com/favicon.ico</url><title>药物简讯 | wechat-feeds</title><link>http://MzI4OTIzMzcwMw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>趋势：主打单品改良抗癌新药，上海谊众药业科创板过会，募资10.3亿</title><link>https://mp.weixin.qq.com/s/q2O28xyllenxXq1XA8zJXA</link><description></description><content:encoded><![CDATA[趋势：主打单品改良抗癌新药，上海谊众药业科创板过会，募资10.3亿]]></content:encoded><pubDate>Wed, 16 Jun 2021 22:12:56 +0800</pubDate></item><item><title>翰森制药携手鱼鹰资管成立博胜药业，完成7200万美元融资</title><link>https://mp.weixin.qq.com/s/ps09dgpOkSgkRc6s-4BT9Q</link><description></description><content:encoded><![CDATA[翰森制药携手鱼鹰资管成立博胜药业，完成7200万美元融资]]></content:encoded><pubDate>Wed, 16 Jun 2021 09:52:53 +0800</pubDate></item><item><title>君实生物拟港股配售新股募资约25亿港元</title><link>https://mp.weixin.qq.com/s/5oak-ZO8FUMELFH3FocVEA</link><description></description><content:encoded><![CDATA[君实生物拟港股配售新股募资约25亿港元]]></content:encoded><pubDate>Wed, 16 Jun 2021 09:52:53 +0800</pubDate></item><item><title>超17亿元！特瑞思引进战略投资，珍宝岛出资4亿元</title><link>https://mp.weixin.qq.com/s/1j27nFYDASPuShWWUYSOfg</link><description></description><content:encoded><![CDATA[超17亿元！特瑞思引进战略投资，珍宝岛出资4亿元]]></content:encoded><pubDate>Wed, 16 Jun 2021 09:52:53 +0800</pubDate></item><item><title>宇道生物完成2000万美元A轮融资</title><link>https://mp.weixin.qq.com/s/d-I1z88FM2flUhusa-IJ7g</link><description></description><content:encoded><![CDATA[宇道生物完成2000万美元A轮融资]]></content:encoded><pubDate>Tue, 15 Jun 2021 16:49:01 +0800</pubDate></item><item><title>奥全生物完成6500万元A轮融资</title><link>https://mp.weixin.qq.com/s/t1FLD4RK0oJkCudu4RYWGA</link><description></description><content:encoded><![CDATA[奥全生物完成6500万元A轮融资]]></content:encoded><pubDate>Tue, 15 Jun 2021 16:49:01 +0800</pubDate></item><item><title>超20亿美元！GSK引进一款I期临床TIGIT单抗，首付款6.25亿美元！</title><link>https://mp.weixin.qq.com/s/FratVsmRGNn3GHSetOAiUA</link><description></description><content:encoded><![CDATA[超20亿美元！GSK引进一款I期临床TIGIT单抗，首付款6.25亿美元！]]></content:encoded><pubDate>Mon, 14 Jun 2021 20:54:18 +0800</pubDate></item><item><title>高诚生物完成7500万美元D轮融资</title><link>https://mp.weixin.qq.com/s/7SwGAjxgqofEyv3keytjlw</link><description></description><content:encoded><![CDATA[高诚生物完成7500万美元D轮融资]]></content:encoded><pubDate>Mon, 14 Jun 2021 20:54:18 +0800</pubDate></item><item><title>创历史：某上市医药企业，出资98亿砸进基金</title><link>https://mp.weixin.qq.com/s/x1IYmdWZ571uz6N_4jY3Bg</link><description></description><content:encoded><![CDATA[创历史：某上市医药企业，出资98亿砸进基金]]></content:encoded><pubDate>Sat, 12 Jun 2021 07:47:24 +0800</pubDate></item><item><title>乳腺癌大癌种：恒瑞CDK4/6即将上市，通用名已出！</title><link>https://mp.weixin.qq.com/s/T_4m_If8OP_RyZ8dHRbegg</link><description></description><content:encoded><![CDATA[乳腺癌大癌种：恒瑞CDK4/6即将上市，通用名已出！]]></content:encoded><pubDate>Wed, 09 Jun 2021 14:51:06 +0800</pubDate></item><item><title>估值惊人，头部基金疯抢：这家国内mRNA药企融资12亿</title><link>https://mp.weixin.qq.com/s/ZznXRACR0VD8YJ1Lz0BkuQ</link><description></description><content:encoded><![CDATA[估值惊人，头部基金疯抢：这家国内mRNA药企融资12亿]]></content:encoded><pubDate>Thu, 03 Jun 2021 06:45:39 +0800</pubDate></item><item><title>创响生物完成1亿美元C轮融资</title><link>https://mp.weixin.qq.com/s/cptwrTyeSNtZrp6PD9syTA</link><description></description><content:encoded><![CDATA[创响生物完成1亿美元C轮融资]]></content:encoded><pubDate>Tue, 01 Jun 2021 06:38:05 +0800</pubDate></item><item><title>启辰生生物完成数亿元Pre A+轮融资，专注mRNA新药开发</title><link>https://mp.weixin.qq.com/s/dymkNPp7KSApVsHgCUaJzQ</link><description></description><content:encoded><![CDATA[启辰生生物完成数亿元Pre A+轮融资，专注mRNA新药开发]]></content:encoded><pubDate>Tue, 01 Jun 2021 06:38:05 +0800</pubDate></item><item><title>投入超6200万元，复星医药的CD73抗体获FDA批临床</title><link>https://mp.weixin.qq.com/s/_EQrjx-CMXn3WmVcnqIiZw</link><description></description><content:encoded><![CDATA[投入超6200万元，复星医药的CD73抗体获FDA批临床]]></content:encoded><pubDate>Mon, 31 May 2021 20:40:34 +0800</pubDate></item><item><title>投入超8200万元，复星MEK1/2抑制剂获FDA批准临床</title><link>https://mp.weixin.qq.com/s/Yfj8X11-1F80FmkrsTMK8A</link><description></description><content:encoded><![CDATA[投入超8200万元，复星MEK1/2抑制剂获FDA批准临床]]></content:encoded><pubDate>Mon, 31 May 2021 20:40:34 +0800</pubDate></item></channel></rss>